To look if post dilatation after stenting has role in patients with ST elevated Myocardial infarctio
Not Applicable
- Conditions
- Health Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified site
- Registration Number
- CTRI/2020/08/027313
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age > 18 years
Gives consent
Acute case of ST elevated Myocardial Infarction with indication for revascularization
After stent deployment, patient should be eligible for either group.
Exclusion Criteria
Pregnancy
Patient with malignancy
Severe left main disease
Cardiogenic shock
Haemody¬namic instability
Bypass graft lesions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To compare clinical, biochemical and angiographic profile of ST elevated Myocardial Infarction patients undergoing PCI with or without post dilatationTimepoint: Patient will be assessed every month for 6 months and TMT will be done after 3 months
- Secondary Outcome Measures
Name Time Method To compare outcome of stent post dilatation in patients with ST elevated Myocardial Infarction. <br/ ><br>Primary Endpoint: Target Vessel Revascularisation (TVR) i.e Stent Thrombosis and ISR <br/ ><br>Secondary Endpoints: MACE like Heart failure, stroke, ischemic cardiovascular events and death <br/ ><br>Timepoint: Symptoms will be assessed for every month for 6 month and TMT will be done at 3 months